Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.
- NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_assertion description "[Eligible patients were older than 18 years of age; had histologically or cytologically confirmed stage IIIB-IV KRAS-mutant NSCLC; had failed first-line therapy for advanced NSCLC; had WHO performance status of 0-1; had not received previous therapy with either a MEK inhibitor or docetaxel; and had adequate bone marrow, renal, and liver function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.
- NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_assertion evidence source_evidence_literature NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.
- NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_assertion SIO_000772 23200175 NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.
- NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_assertion wasDerivedFrom befree-2016 NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.
- NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_assertion wasGeneratedBy ECO_0000203 NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1032551.RACeYSmAKkOV8DInhs6350qDUj6dGyGB25mJP_dBTwIJU130_provenance.